On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
This is a hybrid seminar, in person in the Richard Doll Building and via Zoom.
To join via Zoom, please register in advance for this meeting:
us06web.zoom.us/meeting/register/jJbHX8gQRiSlYH6f2pst7w
After registering, you will receive a confirmation email containing information about joining the meeting.
Speaker Bio: Prof Katie Flanagan is a clinician scientist based in Australia. She is a Professor at RMIT University and University of Tasmania, Director of Infectious Diseases at Launceston General Hospital and Director of the Tasmanian Vaccine Trial Centre. She is a member of the Australian Technical Advisory Group on Immunisation and Past President of the Australasian Society for Infectious Diseases. She completed a PhD in malaria immunology in Adrian Hill’s group in 2000 and has >25 years’ experience conducting vaccine research globally. Her current main research focus involves applying systems biology techniques to study human responses to vaccination, particularly at the extremes of age and pregnancy; and the role that biological sex plays in the vaccine-specific responses and non-targeted effects of vaccines.
